Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Leases (2021 - 2022)

Atea Pharmaceuticals (AVIR) has 2 years of Leases data on record, last reported at $2.5 million in Q3 2022.

  • For Q3 2022, Leases rose 1012.78% year-over-year to $2.5 million; the TTM value through Sep 2022 reached $2.5 million, up 1012.78%, while the annual FY2021 figure was $161000.0, N/A changed from the prior year.
  • Leases reached $2.5 million in Q3 2022 per AVIR's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Leases topped out at $2.9 million in Q1 2022 and bottomed at $161000.0 in Q4 2021.